Gloria Sola-Alvarez
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 05, 2022
Bile Processing Protocol for Improved Proteomic Analysis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 14, 2021
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: February 05, 2020
Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: October 01, 2018
Fibroblast growth factors 19 and 21 in acute liver damage.
Journal: Annals of translational medicine
Published: August 03, 2018
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.
Journal: Nucleic acids research
Published: July 26, 2018
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Journal: Hepatology (Baltimore, Md.)
Published: May 29, 2018
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: April 07, 2018
Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice.
Journal: Cell death & disease
Published: June 02, 2017
Last Updated: 09/26/2026